SCHEMBL10429349

SCHEMBL10429349

COc1ccc(-c2nccc3c(=O)[nH]nnc23)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 2/20 0.43
PDE4B Q07343 2/20 0.43
PDE4C Q08493 2/20 0.43
PDE4D Q08499 2/20 0.43
KMO O15229 2/20 0.42
RAF1 P04049 1/20 0.38
BRAF P15056 1/20 0.38
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
GLO1 Q04760 1/20 0.36
MAOB P27338 3/20 0.35
SYK P43405 1/20 0.35
TNKS O95271 1/20 0.35
TNKS2 Q9H2K2 1/20 0.35
PARP2 Q9UGN5 1/20 0.35
GRM4 Q14833 1/20 0.35
CCNT1 O60563 1/20 0.35
CDK9 P50750 1/20 0.35
PTGS2 P35354 2/20 0.34
DYRK1A Q13627 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10429333 0.86 PDE4A (0.43) PDE4APDE4BPDE4CPDE4DRAF1
SCHEMBL10429318 0.83 PDE4A (0.40) PDE4APDE4BPDE4CPDE4DSYK
SCHEMBL10429360 0.80 PDE3B (0.50) TNKSTNKS2DYRK1A
SCHEMBL7162696 0.77 PDE4A (0.38) PDE4APDE4BPDE4CPDE4DKMO
SCHEMBL10429297 0.73 NPSR1 (0.47)
SCHEMBL17950587 0.69 KDM5B (0.36) CDK9DYRK1A
SCHEMBL10429345 0.69 TDO2 (0.51) KMORAF1ADORA2AADORA1MAOB
SCHEMBL19153242 0.68 PDE3B (0.40) DYRK1A
SCHEMBL873985 0.67 TNKS (0.51) PDE4APDE4BPDE4CPDE4DTNKS
SCHEMBL10189786 0.67 KDM4E (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0274654-A2 1,2,3-Triazin-4(3H)-one derivatives, process for their preparation and medicaments containing them F. HOFFMANN-LA ROCHE AG (CH) 1988-07-20 EP claimed
US-4920119-A XANTHINE OXIDASE INHIBITORS; CONTROL OR PREVENTION OF GOUT OR ISCHEMIA HOFFMANN-LA ROCHE INC. (US) 1990-04-24 US disclosed
EP-0274654-A2 1,2,3-Triazin-4(3H)-one derivatives, process for their preparation and medicaments containing them F. HOFFMANN-LA ROCHE AG (CH) 1988-07-20 EP disclosed